In addition, survivin is expressed at higher levels in adamantinomatous craniopharyngioma compared with squamous-papillary craniopharyngioma, which may partially explain the higher recurrence rate of the adamantinomatous tumor type. This evidence concerns the gene BIRC5 and Adamantinomatous Craniopharyngioma.